Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for COVID-19 and Post-COVID Pulmonary Fibrosis
NCT04818489Phase 4Unknown
- Sponsor
- ClinAmygate
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in coronavirus disease 2019 (COVID-19), pulmonary fibrosis (PF), sponsored by ClinAmygate. Status: unknown.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT04818489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818489.